| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9247 |
| Human Intestinal Absorption | HIA- | 0.7893 |
| Caco-2 Permeability | Caco2- | 0.8094 |
| P-glycoprotein Substrate | Non-substrate | 0.8448 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9749 |
| Non-inhibitor | 0.9916 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9532 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7753 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7927 |
| CYP450 2D6 Substrate | Non-substrate | 0.8454 |
| CYP450 3A4 Substrate | Non-substrate | 0.7368 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9304 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9160 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9384 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9247 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9442 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9768 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9203 |
| Non-inhibitor | 0.9602 |
| AMES Toxicity | Non AMES toxic | 0.9303 |
| Carcinogens | Carcinogens | 0.6126 |
| Fish Toxicity | Low FHMT | 0.7692 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7328 |
| Honey Bee Toxicity | High HBT | 0.7957 |
| Biodegradation | Not ready biodegradable | 0.7546 |
| Acute Oral Toxicity | III | 0.8267 |
| Carcinogenicity (Three-class) | Non-required | 0.6036 |